Aniracetam is a racetam-class small molecule studied in vitro as a positive allosteric modulator of the AMPA subtype of glutamate receptor. This profile describes its structure, its molecular target, and the laboratory assays used to characterize it.
What is aniracetam?
Aniracetam is a member of the racetam chemical family. In research it is used as a reference compound for studying the AMPA receptor, a glutamate-gated ion channel found on neurons. It is a laboratory material, described here only by structure and mechanism.
What does it target in vitro?
Its studied target is the AMPA receptor. As a positive allosteric modulator, it is examined for binding a site distinct from the receptor's main glutamate-binding site and altering how the receptor behaves, specifically the kinetics of the ion current the receptor passes.
How is aniracetam characterized in the lab?
The main tools are patch-clamp electrophysiology on cultured neurons, which records AMPA-receptor currents directly, and receptor-binding assays, which quantify the compound's interaction with the receptor. In electrophysiology, aniracetam is studied for its effect on the decay kinetics of AMPA-receptor currents.
Why this matters in receptor research
Allosteric modulators of glutamate receptors are useful tools for probing how these channels operate. A well-characterized modulator like aniracetam lets researchers study AMPA-receptor behavior under controlled in-vitro conditions.
Related research guides
- Nootropic research compounds: receptor targets and in-vitro models
- Racetams vs. research peptides: targets and assays
- Semax: a short peptide and its research targets
Research-use note
Aniracetam is supplied as a research material for in vitro research use only. It is not for human or animal use.
